HEALTH CARE RESOURCE UTILIZATION AND COSTS OF CARDIOEMBOLIC STROKE IN THE REGION OF MADRID, SPAIN- PRELIMINARY RESULTS OF CODICE STUDY
Author(s)
de Andres F1, Vivancos J2, Barriga FJ3, Diaz F4, Izquierdo L5, Ortega MA6, Castillo L3, Ximenez-Carrillo A2, Martin MP4, Gomez-Escalonilla CI5, Torres C1, de Salas-Cansado M7, Casado MA1, Soto J8, Gil-Nuñez A41Pharmacoeconomics & Outcomes Research Iberia, Madrid, Madrid, Spain, 2Hospital Universitario de La Princesa, Madrid, Madrid, Spain, 3Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain, 4Hospital General Universitario Gregorio Marañón, Madrid, Madrid, Spain, 5Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain, 6Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain, 7Pfizer Spain, Alcobendas, Madrid, Spain, 8Pfizer España, Alcobendas/Madrid, Spain
OBJECTIVES: To estimate the healthcare resource utilization and direct costs of cardioembolic stroke in patients treated in public hospitals of the Region of Madrid (Spain). METHODS: An observational, prospective study was performed in 5 Neurology services from hospitals in the Region of Madrid, 2 with stroke units (SU) and 3 without stroke units (wSU). Patients with a diagnosis of cardioembolic stroke with ≤48-hours were recruited in a 4-month period in 2012. Patients’ socio-demographic, clinical data: disability (modified Rankin scale, mRs), hospital stay and mortality; complications and healthcare resource utilization (hospitalisation, in-patient and at discharge rehabilitation, medication, laboratory tests and specific therapeutic interventions) were collected. Unitary costs were obtained from national healthcare database and the Spanish Catalogue of Medicinal Products (€, year 2012). RESULTS: Preliminary results from 76 patients (25 SU, 51 wSU) were: mean age, 74.2±1.42; 64.5% female; mean mRs at discharge, 2.02±0.20; non-valvular atrial fibrilation was the main cause of cardioembolic stroke (28.9%); mean length of stay, 10.1±1.14 days; mortality, 5.3%; 42 patients (68.4%) needed in-patient rehabilitation and 48 patients (63.2%) needed rehabilitation after hospital discharge; 22 patients (28.9%) suffered hospital complications (63.6% of them suffered infections, 27.3% cardiovascular complications and 59.1% others). Healthcare resource utilization differences between SU and wSU hospitals were found in: length of stay (7.2±1.26 days, SU; 11.6±1.55 days, wSU; p-value=0.014) and specific therapeutic interventions (41.7%, SU; 8.0%, wSU; p-value=0.001). The overall 4-month cost per patient was 13,647€ (49.2%, hospital stay; 24.8%, rehabilitation at discharge). CONCLUSIONS: Cardioembolic stroke imposes significant economic burden for the Public Health System in the Region of Madrid. Key cost drivers were hospital stay and patients’ rehabilitation at discharge. Patient management in SU hospitals was associated with more specific therapeutic interventions and shorter hospital stay than hospitals wSU.
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PCV29
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Cardiovascular Disorders, Respiratory-Related Disorders
Explore Related HEOR by Topic